Rigel Pharmaceuticals Inc...

NASDAQ: RIGL · Real-Time Price · USD
39.55
1.66 (4.38%)
At close: Aug 15, 2025, 3:59 PM
39.51
-0.10%
After-hours: Aug 15, 2025, 07:58 PM EDT

Rigel Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
267.92M 203.08M 179.28M 157.47M 130.3M 120.35M 116.88M 88.84M 83.12M 86.05M 76.72M 89.37M 88.51M 84.95M 149.24M 147.28M 144.12M 133.88M
Cost of Revenue
22.73M 21.03M 18.65M 16.65M 9.89M 8.16M 7.11M 3.66M 2.64M 2.6M 1.75M 1.89M 1.79M 888K 1.08M 917K 906K 1.06M
Gross Profit
245.19M 182.05M 160.63M 140.83M 120.41M 112.19M 109.77M 111.34M 106.64M 109.61M 101.13M 87.48M 86.71M 84.06M 148.15M 146.36M 143.22M 132.82M
Operating Income
104.59M 43.93M 24.19M 9.5M -9.02M -14.73M -20.49M -20.38M -34.32M -42.01M -55.55M -79.05M -80.43M -80.51M -12.5M -9.9M -3.9M -8.24M
Interest Income
2.29M 2.09M 2.09M 2.25M 2.5M 2.47M 2.27M 2.02M 1.54M 1.06M 684K 271K 93K 67K 47K 50K 72K 225K
Pretax Income
99.14M 38.12M 18.37M 3.88M -14.23M -19.8M -25.09M -24.43M -37.77M -44.66M -58.57M -82.67M -84.73M -86.03M -17.31M -13.85M -6.93M -9.72M
Net Income
97.82M 37.18M 17.48M 3.88M -14.23M -19.8M -25.09M -24.43M -38.41M -45.3M -59.21M -83.25M -84.53M -84.86M -17.91M -14.51M -7.73M -11.49M
Selling & General & Admin
113.53M 112.33M 113.06M 110.39M 108.2M 106.46M 105.74M 111.06M 112.1M 112.78M 112.45M 104.79M 101.77M 97.17M 91.89M 89.19M 83.75M 80.29M
Research & Development
27.07M 25.79M 23.38M 20.93M 21.23M 20.46M 24.52M 36.7M 44.89M 54.89M 60.27M 58.21M 61.84M 63.88M 65.24M 67.07M 63.37M 60.78M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 1.32M 1.32M 1.32M 1.32M 3.52M 3.52M 3.52M 3.52M n/a n/a n/a
Operating Expenses
140.61M 138.12M 136.44M 131.32M 129.43M 126.92M 130.26M 149.08M 158.32M 168.99M 174.04M 163M 163.62M 161.06M 157.13M 156.26M 147.12M 141.07M
Interest Expense
7.74M 7.9M 7.92M 7.87M 7.71M 7.54M 6.87M 6.07M 5M 3.71M 3.71M 3.9M 4.39M 5.58M 4.86M 3.99M 3.1M 1.7M
Selling & Marketing Expenses
n/a n/a n/a 544K 544K 544K 544K n/a n/a n/a n/a n/a n/a n/a n/a 3.39M 3.39M 3.39M
Cost & Expenses
163.33M 159.15M 155.09M 147.97M 139.32M 135.08M 137.37M 150.75M 158.96M 169.59M 173.79M 168.42M 168.94M 165.47M 161.73M 157.18M 148.02M 142.12M
Income Tax Expense
1.31M 946K 881K n/a n/a n/a n/a n/a 634K 634K 634K 574K -196K -1.17M 605K 478K 650K 1.79M
Shares Outstanding (Basic)
17.89M 17.81M 17.65M 17.6M 17.55M 17.52M 17.45M 17.25M 17.36M 16.92M 17.29M 17.28M 17.21M 17.18M 17.11M 17.09M 17.02M 16.98M
Shares Outstanding (Diluted)
18.16M 18.17M 17.69M 17.65M 17.55M 17.52M 17.45M 17.44M 17.36M 17.36M 17.29M 17.28M 17.21M 17.18M 17.11M 17.09M 17.02M 17.61M
EPS (Basic)
5.49 2.10 0.99 0.22 -0.82 -1.14 -1.45 -1.41 -2.18 -2.58 -3.4 -4.8 -4.93 -4.96 -1.03 -0.85 -0.46 -0.69
EPS (Diluted)
5.42 2.08 0.98 0.21 -0.82 -1.14 -1.47 -1.43 -2.2 -2.6 -3.4 -4.78 -4.91 -4.94 -1.14 -0.94 -0.55 -0.78
EBITDA
109.3M 47.9M 27.96M 13.12M -5.47M -10.97M -16.97M -17.12M -31.6M -39.84M -53.87M -77.66M -79.2M -79.28M -11.29M -8.89M -2.96M -7.25M
EBIT
106.88M 46.02M 26.28M 11.75M -6.52M -12.26M -18.22M -18.36M -32.77M -40.96M -54.87M -78.78M -80.34M -80.44M -12.45M -9.86M -3.83M -8.02M
Depreciation & Amortization
2.43M 2.43M 2.23M 1.92M 1.61M 1.29M 1.25M 1.24M 1.18M 1.12M 998K 1.12M 1.14M 1.16M 1.16M 964K 868K 774K